Methods and compositions for the dietary management of autoimmune disorders
AssigneeGaneden Biotech, Inc.
InventorsSean Farmer, Andrew R. Lefkowitz
Life of this patent
Estimating the term…
Abstract
The present invention describes the use of lactic acid bacteria, particularly lactic acid producing members of the genus Bacillus, in treating digestive-related immune disorders by downregulating of cytokines and by inhibiting pathogenic or deleterious microorganisms in the gastrointestinal tract. Specific formulations of Bacillus coagulans for various immune disorders are elaborated.
Claims19
A method for decreasing serum TNF-α levels in a mammal, comprising identifying a mammal comprising an elevated level of TNF-α and orally administering to said mammal a composition comprising Bacillus coagulans bacteria, wherein serum TNF-α levels are decreased in said mammal following said administration when compared to serum TNF-α levels in said mammal prior to said administration.
Dependencies are inferred from the claim text.